Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / @xirurgi_2025 / @xirurgi_2025 - 756 - файл
.pdf
498
https://t.me/med1917
asymptomatic bacteriuria but to treat only if symptomatic [31]. Preoperative respiratory infections, such as pneumonia or COVID-19, have been identied as risk
factors for increased postoperative mortality and complications such as prolonged
ventilation or need for reintubation [32–34]. It is recommended that surgery be
delayed, if possible, until any respiratory infection is treated.
R. Parrish and R. Findley
Tobacco Use
Tobacco use is associated with increased risk of POCs including wound healing
concerns, infection, pulmonary complications, and prolonged LOSH [35–37].
Historic observations suggested there was increased sputum production and change
in cough if smoking stopped within a few weeks of surgery. This has not been substantiated and a meta-analysis demonstrated that there is no increased risk of POCs
if smoking cessation occurs within 8weeks of an operation [35].
While increased complications with smoking cessation have not been shown, a
reduction in POCs has also not been denitively shown if there is a short interval
between cessation and surgery [37]. Behavioral support and nicotine replacement
therapy may improve short-term smoking cessation complaints and should be
offered to help minimize discomfort [38]. For motivated patients wishing long-term
cessation, there is evidence of benet for intensive intervention started at least
4weeks prior to surgery. These patients may have fewer complications overall, with
a potentially signicant reduction in wound complications [38].
Ethanol Use
Alcohol use is common among patients and national guidelines substantially vary
on recommended daily maximum intake. High alcohol intake, or “risky drinking,”
can be tentatively dened as more than three alcoholic units per day or 21 per week.
Indeed, the World Health Organization states that no level of alcohol consumption
is safe for health. One unit equals 12g of ethanol in Italy, Sweden, and some other
parts of Europe, or one small glass of wine, with a worldwide range of 8–20g/unit
[39]. While alcohol use can cause disorders of the liver, pancreas, and nervous system, it may also impact other physiologic systems that increase the risk for perioperative complications. Alcohol intake greater than three units per day can
compromise the immune response, increase the risk of cardiac insufciency and
arrhythmias, and alter blood clotting time [39].
Available data suggests that short and long-term interventions can decrease alcohol use in the perioperative period, but data are lacking on whether there is a corresponding reduction in complication rates [39]. Preoperative alcohol screening is
encouraged to prevent POCs from alcohol withdrawal syndrome, nominally delir-
ium tremens which can impact LOSH as well as mortality [40].

29 Optimal Pharmacotherapy Strategies for Enhanced Postoperative Recovery…
https://t.me/med1917
499
Nutritional Status
At least 30% of hospitalized patients undergoing major surgery are malnourished
[41, 42]. Malnutrition is an independent predictor of POCs including increased
LOSH in both the oncologic and non-oncologic patient group [41, 43, 44]. Large
data available from the National Surgical Quality Improvement Program (NSQIP)
identies malnutrition as a modiable risk factor for reducing postoperative mortality and morbidity [42, 43]. The impacts of malnutrition are broad, including
impaired immune function, changes in digestion and absorption, muscle weakness
leading to respiratory complications, and wound healing troubles [45].
Dening malnutrition can be challenging. Measurement of serum albumin can
be applied to preoperative patients; however, it can be impacted by stress, infection,
and organ dysfunction separate from malnutrition [46]. Albumin levels lower than
3g/dL are associated with signicantly higher rates of POCs and 30-day mortality
[43]. Other studies suggest that an even higher threshold for hypoalbuminemia
should be considered, with a cutoff of 4g/dL [41]. Body mass index (BMI) may
also be a surrogate marker for malnutrition as those with a BMI less than 18.5kg/
2
m
, or less than 20kg/m2 if older than 65, have higher rates of POCs [42]. A more
formal assessment of nutrition status such as the Perioperative Nutrition Screen
(PONS) integrates BMI, recent unintentional weight loss, dietary intake, and serum
albumin, and vitamin D levels to provide a risk score. It is recommended that those
at high risk for malnutrition see a registered dietician for preoperative nutritional
optimization [42].
Nutritional support in malnourished patients should ideally begin preoperatively
and continue postoperatively [44, 46]. Enteral nutrition is the preferred method for
improving nutrition. Optimizing protein intake can reduce complication rates when
started at least 5–7 days prior to major surgery [44, 46]. Use of parenteral nutrition
is not recommended as there may be increased risk of POCs and infection. This
should only be considered in those with an absolute contraindication to enteral feeding [44, 46].
Anemia
Anemia affects at least one-third of preoperative patients [47–49]. Iron deciency
anemia is the most common cause of anemia preoperatively [47, 49]. Preoperative
anemia is associated with higher rates of postoperative mortality and morbidity
including SSI, cardiac events, and LOSH [47, 49].
Mainstay of treatment is iron supplementation, and red blood cell transfusion
should be avoided. Iron can be supplemented either orally or parenterally [47, 49].
Oral iron supplementation must be started 1 or 2 months in advance of surgery
whereas parenteral iron should be given at least 2weeks preoperatively [49, 50].
The use of recombinant erythropoietin (EPO) to stimulate hematopoiesis in bone

500
https://t.me/med1917
marrow has come in and out of favor since it became available [45, 47, 48]. Metaanalysis of available studies suggest that EPO in combination with iron supplementation does reduce the risk of transfusion perioperatively [47, 46]. Increased risk of
thromboembolism with recombinant EPO products was a concern, but newer
research suggests that those risks may be higher in prolonged use of EPO, while
short term use immediately preoperatively may not have the same risk [47]. Given
this, recombinant EPO can be considered along with iron supplementation in wellselected patients requiring correction of preoperative anemia and to support blood
conservation management strategies [50].
R. Parrish and R. Findley
High-Risk, Non-cardiovascular Surgeries
High-risk surgeries are dened as procedures with possible signicant effect on
hemodynamics and blood loss. These procedures include colorectal surgery with
bowel resection; kidney transplant; major joint replacement (shoulder, knee, and
hip); open radical prostatectomy or cystectomy; and major oncologic general, gynecologic, or head and neck surgery.
Common Postoperative Complications
Nausea andVomiting
Postoperative nausea and vomiting (PONV) are common complications of surgery
and optimal management is sometimes complex [51]. Risk factors include female
gender, a history of PONV or motion sickness, nonsmokers, and young age. The
choice of anesthetic during surgery can impact these rates. Avoidance of opioids has
been shown to reduce PONV and options include opioid-free total intravenous anesthesia (TIVA), regional anesthesia, multimodal analgesia, beta-blockers, and administration of alpha-agonists [51]. Nitrous oxide is a likely risk factor for PONV, but it
appears to be related to exposure time as use less than an hour has a signicantly
lower risk of PONV compared to longer exposures [51].
Preoperative prophylactic acetaminophen signicantly decreases opioid use and
reduce rates of PONV.Intravenous use is best studied, but oral prophylaxis reduces
opioid use and is less expensive [51]. Alpha-2 adrenergic receptor agonist dexmetomidine administration prior to skin incision also reduces opioid use and PONV [51].
Use of neuraxial anesthesia, such as epidural anesthesia and transversus abdominus
plane (TAP) blocks are other interesting alternatives [51].
Pharmacologic prophylaxis is recommended and newer guidelines suggest multimodal prophylaxis in those with one or more risk factors. Serotonin 5-HT3 receptor antagonists can be combined with dexamethasone, aprepitant, haloperidol, or
betahistine. Non-5HT3 receptor antagonist containing combinations are also
described [51].

29 Optimal Pharmacotherapy Strategies for Enhanced Postoperative Recovery…
https://t.me/med1917
501
In those exhibiting PONV despite prophylaxis, using a pharmacologic agent
from a different class is recommended as repeated dose of the former options within
6h has not been shown to provide additional benet [51]. In those who did not
receive prophylaxis, 5-HT3 receptor antagonists are the rst-line therapy for treating PONV.Nonpharmacologic therapies such as aromatherapy with isopropyl alcohol or peppermint oil, ginger, and PC6 acupressure may all reduce PONV [51, 52].
Postoperative Ileus (Delayed Gastric Emptying)
Early feeding and early mobilization signicantly reduce the rate of postoperative
ileus and are core components of ERAS® pathways [53, 54]. Epidural analgesia is also
associated with a reduction in ileus compared to systemic analgesia, but may not benet LOSH [53]. Selective use of nasogastric tube drainage is recommended along with
early removal [54]. A variety of pharmacologic and nonpharmacologic approaches
has been trialed in the prevention of ileus, without consistent outcomes [55, 56].
The peripherally acting mu-opioid receptor antagonist, alvimopan, signicantly
reduces the time to bowel recovery. Side-effects include hypokalemia and insomnia
[57]. Methylnaltrexone and ghrelin receptor agonists do not reliably reduce the risk
of ileus [57]. Data on serotonin receptor agonists as prophylaxis are more limited
but mosapride may reduce the time to bowel recovery, whereas metoclopramide
does not appear to reliably reduce ileus [57].
Glycemic andElectrolyte Imbalances
Perioperative glycemic control is recommended by most major societies as a strategy
to reduce infections complications, lower mortality, and shorten LOSH [58]. This
applies to both diabetic and non-diabetic patients. Attention should be paid to which
agents are most likely to cause hypoglycemia in patients who are nil per os (NPO),
as this is a potentially serious side-effect of anti-diabetic drugs. These higher risk
agents, such as short-acting insulin, SGLT-2 inhibitors, meglitinides, and sulfonylureas, should be held until patients are eating well [58]. Other agents can be continued throughout the perioperative period with attention paid to a dose reduction for
long-acting insulins [58]. In North America, it is common practice to withhold metformin perioperatively; however, this agent does not cause hypoglycemia and the
risk of lactic acidosis is extremely low. Given this, it should only be held if the
patient’s eGFR is less than 30mL/min/1.73m
levels above 180mg/dL (10mmol/L), intervention with basal bolus insulin therapy
reduces POCs in comparison with traditional sliding-scale insulin regimens [58, 59].
Major electrolyte disturbances can occur in the postoperative period. Patients at
higher risk include those with AKI, malnourished patients experiencing refeeding
syndrome, patients with a malignancy, and those in the intensive care unit.
2
[58]. In patients with blood glucose

502
https://t.me/med1917
Disturbances in sodium levels are typically related to imbalances in total body water
with correction being achieved after assessment for total body water excess or decit. Treatment of hyperkalemia requires removal of additional potassium supplementation in uids and binding or shifting potassium to facilitate removal. If there
are no ECG changes and the patient has a functional bowel, then an oral agent such
as sodium polystyrene (Kayexalate) can be used. If more urgent shifting is required,
this can be achieved with insulin with accompanying glucose. If ECG changes are
present, a parenteral dose of calcium is required for myocardial stabilization.
In the event of hypokalemia, this is replaced orally if the patient is asymptomatic
and tolerating enteral nutrition, with the parenteral route used for symptomatic
patients, those who cannot tolerate oral supplementation, or those with critically
low values. Muild hypophosphatemia and hypomagnesemia are replaced with oral
supplementation. Parenteral supplementation is indicated if the refeeding syndrome
is suspected, or in those not tolerating enteral nutrition. Magnesium should be
infused over a prolonged period, ideally 24h at up to 1g/h, to maximize absorption
and minimize renal excretion [60].
R. Parrish and R. Findley
Acute Kidney Injury
Acute kidney injury (AKI) occurs with an increase in serum creatinine by 50% or
greater within 7days, of greater than or equal to 0.3mg/dL (26.5mmol/L) within
48h, or oliguria in face of adequate uid intake [61]. Postoperative AKI is associated with increased mortality and LOSH, as well as subsequent chronic kidney disease [61]. The mechanism leading to kidney injury is often multifactorial and can
include perfusion related injuries, nephrotoxic medications, urologic obstruction,
and vasoconstriction [61]. Nephrotoxic medications may play a role in up to 30% of
AKI [61].
NSAIDs may contribute to postoperative AKI, and routine prescription of 0.9%
saline is associated with more postoperative AKI compared to balanced crystalloids
in those at high risk [62]. Hypotension and prolonged hyperglycemia are both recognized mechanisms [62]. If AKI is recognized, it is key to remove nephrotoxic
medications and treat the underlying causes. Initial expansion of the intravascular
volume is recommended with balanced crystalloids as opposed to colloids such as
albumin. Diuretics can be initially tested provided hydration is maintained
(euvolemia), and may be required if there is evidence of volume overload [62].
Urinary Retention
The incidence of postoperative urinary retention varies from 5% to 70% [63]. Risk
factors include age over 50, male gender, major abdominal or pelvic surgery, neurologic complications (such as diabetic neuropathy, stroke, multiple sclerosis),

29 Optimal Pharmacotherapy Strategies for Enhanced Postoperative Recovery…
https://t.me/med1917
prolonged surgery duration, medications, and receiving excess perioperative intravenous uids [63]. Urinary retention has been precipitated by medications such as
anticholinergics, opioids, anesthetics, alpha-adrenergic agonists, calcium channel
blockers, detrusor relaxants, and benzodiazepines. Their prescription should be
carefully analyzed in those with prostate hypertrophy or previous history of urinary
retention [63, 64].
Standard of care management of urinary retention is bladder catheterization,
whether this be intermittent or indwelling [63]. Prophylactic alpha-adrenergic
blockers such as tamsulosin may attenuate urinary retention in both men and
women; however, results are inconsistent [63, 65, 66].
503
Venous Thromboembolism (VTE)
VTE includes deep vein thrombosis and pulmonary embolism. These are common
complications, occurring at rates of 15–38% and just under 1%, respectively, in
those undergoing major general or gynecology surgery who do not receive prophylaxis [67, 68]. Appropriate thromboprophylaxis can reduce the rate of VTE by
30–65% with low risk of complications [67]. Studies indicate that despite recommendations 40–60% of patients don’t receive appropriate prophylaxis [67].
Conventional guidelines with injectable drugs recommend thromboprophylaxis
for all major general, gynecologic, and open urology operations with either low
molecular weight heparin/ LMWH, low-dose unfractionated heparin (UFH), or subcutaneous fondaparinux [68]. In gynecologic oncology surgery VTE is decreased
by just over 40% with either LMWH or low-dose UFH [67]. Giving aspirin alone is
not deemed sufcient in any patient group [68]. Direct oral anticoagulants/DOAC
for extended prophylaxis appear to provide a safe alternative to injectable medications and may be more acceptable to patients [69]. The recommended length of
postoperative prophylaxis varies widely among surgical groups, procedure type,
and patient factors such as malignancy.
Blood Pressure Management
While blood pressure targets for ambulatory patients are clearly dened and wellresearched, optimum blood pressure targets in the perioperative setting are less clear
[70]. Intraoperative hypotension in non-cardiac surgery is associated with increased
morbidity including cardiac and renal dysfunction, delirium, and postoperative
mortality [70]. Intraoperative hypertension is not reliably associated with POCs
[70]. Based on the available evidence for those undergoing non-cardiac surgery,
identifying the patient’s baseline blood pressure, and maintaining intraoperative
blood pressure within a range of up to 10% variance is suggested [70].

504
https://t.me/med1917
R. Parrish and R. Findley
Postoperative Hypotension/Hypertension
A systolic blood pressure of less than 90mmHg has been found to increase the risk
of myocardial injury, stroke, and mortality [71]. This threshold may be higher in
someone with preoperative hypertension and avoiding a drop in blood pressure by
more than 30% of the patient’s baseline is suggested [71]. While many patients have
a natural drop in their blood pressure by 10–20% while sleeping, some do not.
Therefore, it is important to not ignore prolonged periods of hypotension unless the
patient has been demonstrated to have lower blood pressures out of hospital [71].
Postoperative hypertension (systolic pressure greater than 180mmHg) is associated with increased risk of heart attack, arrhythmia, pulmonary complications,
stroke, and bleeding [71]. Curiously there is no demonstrated benet from lowering
blood pressure substantially below 180mmHg postoperatively [71].
Cardiologic Medications
Continuing already prescribed beta-blockers postoperatively decreases short and
long-term mortality. Conversely, holding a beta-blocker has been shown to increase
mortality in those undergoing vascular surgery. A beta-blocker should be held postoperatively if a patient develops a third-degree heart block and the dose titrated or
held in the setting of hypotension or severe bradycardia [71]. Angiotensin-converting
enzyme inhibitors/ACEI and angiotensin receptor blockers/ARB should be restarted
within 48h of surgery unless the patient has an elevation in creatinine levels or low
blood pressure. Failure to restart these agents is associated with an increase in
30-day mortality, especially in those under age 60 [71]. Calcium channel blockers/
CCBs may reduce cardiac ischemia and arrhythmia in the perioperative period but
guidance on reintroduction of these agents is limited by lack of evidence [71].
Similarly, evidence is limited on management of diuretics [71].
Atrial Fibrillation
Atrial brillation (AFib) occurs in up to 10% of patients undergoing non-cardiac
surgery and the vast majority will revert to sinus rhythm prior to discharge [72].
Despite this, perioperative AFib is associated with an increased risk of early and late
stroke (62% higher odds of early, 37% higher odds of late) and mortality (37–44%
higher odds), particularly in those undergoing non-cardiac surgery [72]. In the
POISE trial evaluating prophylactic metoprolol in the perioperative period, there
were fewer new AFib events however signicantly higher rates of mortality and
stroke [71, 72]. Therefore this practice is not encouraged. In contrast meta-analyses
with cardiac surgery cohorts identied risk reduction with such drugs as amiodarone, landiolol, and colchicine.

29 Optimal Pharmacotherapy Strategies for Enhanced Postoperative Recovery…
https://t.me/med1917
Patients experiencing AFib in the perioperative period should be managed similar
to those in the ambulatory setting. An assessment for predisposing factors preceding
the AFib event is key, along with an evaluation on the need for ongoing anticoagulation [73]. According to Canadian guidelines, beta-blockers or nondihydropyridine
calcium channel blockers (verapamil, diltiazem) should be considered as rst-line
therapy for rate control in those with normal cardiac ejection fraction. Cardioversion
should be considered for any patients deemed to be vitally unstable [73].
505
Shock andHemorrhage
In patients with postoperative shock, 30-day mortality rate is as high as 26%, and
independent factors associated with short-term prognosis are the severity of clinical
status at ICU admission, worsening organ dysfunction during the rst 3 days of ICU
admission, and intraoperative coagulation disturbances [74]. The rst 3 days of ICU
admission are important for overall survival [74]. Long-term mortality (>6months)
is also associated with worsening early organ dysfunction, especially hepatic dysfunction, and intraoperative coagulation disturbances, and the impact of comorbidities [74]. The evolving concept of perioperative goal-directed uid (hemodynamic)
therapy (GDFT) currently includes the use of uids and/or vasopressors to reach and
maintain hemodynamic endpoints (systolic pressure>90mmHg, mean arterial pressure 60–65mmHg) and minimize postoperative circulatory complications [75, 76].
Perioperative GDFT to optimize uid status and hemodynamics, with the appropriate use of uids as well as the use of earlier/preemptive inotropes and vasopressors
has been adopted in some centers, however not in others [75]. Vasopressor selection
(dopamine, norepinephrine, epinephrine, phenylephrine, vasopressin) should be
based on rectifying underlying physiologic decits. Practically speaking, which agent
is chosen initially does not seem as important as reaching and maintaining hemodynamic goals. A supraphysiologic goal for cardiac output has not been benecial and
may cause morbidity [75]. A second medication with a different mechanism of action
should be added when maximum doses of the initial agent are inadequate [75].
Myocardial Infarction inNon-cardiac Surgeries
Cardiogenic shock (CS) is a feared complication of acute myocardial infarction
(AMI), and the mortality rate of patients with CS as a result of AMI is around
40–50%, within any setting [76]. Progression from AMI to CS can develop within
hours after severe AMI, as a result of left ventricular systolic and diastolic dysfunction (most common), acute mitral regurgitation, ventricular septal rupture, isolated
right ventricular failure, tamponade or cardiac rupture [76]. While guidance for
optimal pharmacologic therapy in patients with CS after AMI is scarce, guidelines
recommend avoiding renin-angiotensin-aldosterone system inhibitors and betablockers until shock resolves [76].

506
https://t.me/med1917
R. Parrish and R. Findley
Surgical Site Infection
After implementing an ERAS® protocol for colorectal surgeries, a 2.5-fold decrease
in SSI rate has been announced even if compliance with other individual bundle
items is below 50%. However, compliance with preoperative antibiotic administration alone is associated with improved outcomes [77]. Alternative non- cephalosporin
regimens, especially ertapenem, may be as effective as cephalosporin-based regimens for preventing 30-day SSI; however, recent evidence suggests that alternative
regimens may lead to worse outcomes [78].
Evidence of at least moderate certainty indicates reduced SSI risk when IV antibiotics are administered prior to cesarean incision, breast cancer surgery, and hernia
repair. Iodine-impregnated adhesive drapes are not recommended, and there is probably no difference in SSI risk when antibiotics are stopped the day of surgery compared to longer duration during colorectal surgery [79]. Optimization of stroke
volume and cardiac output is defended by some, so that circulation to the surgical
wound area is not compromised [80].
GDFT seems to reduce SSI in cardiac, gastrointestinal, and other non-cardiac
surgeries, but not in vascular or orthopedic procedures [80]. Respiratory and urinary
system infectious complications were also less frequent, however not sepsis or septic shock [80]. Visceral surgery patients with reported penicillin allergy can be
treated with a cephalosporin or ertapenem; however, true cephalosporin allergy
requires alternative therapy with gentamicin and clindamycin or metronidazole
[81]. Oral antibiotic gut sterilization has very rare indications nowadays, and even
for laparoscopic bowel and rectal procedures it is sometimes questioned [55].
Pain Management
As many as 55% of patients have POCs that are related to higher pain levels [82].
Diabetes is an independent predictor of postoperative pain, and about 30% of diabetics experience neuropathic pain [80]. Younger patients experience more pain
intensity and this could be explained by reduced renal clearance of opioids in the
elderly [82]. See Table29.3 for a suggested multimodal protocol which reduced the
frequency and severity of postoperative pain by 50% in colorectal surgery [82].
Minimally invasive surgery (MIS) is deemed less painful than open surgery, however outcomes are inconsistent, for instance when anterior rectal resection and
abdominal perineal rectal excision modalities are compared [82].
IV lidocaine, although benecial in select cases, is currently not considered the
standard of care for acute pain management due to the primarily observational data
supporting its safe and effective use, with scarce prospective protocols [83].
Compared with sufentanil, hydromorphone may signicantly reduce postoperative
pain, with no signicant difference in sedation and patient-controlled analgesia
requests. In addition, the incidence of PONV and somnolence with hydromorphone
could be lower [84].

29 Optimal Pharmacotherapy Strategies for Enhanced Postoperative Recovery…
https://t.me/med1917
507
Table 29.3
Pharmacotherapy recommendations for preventing common postoperative
complications (expanded from Parrish etal. [1])
Postoperative
complication Recommendations (consider alternatives for shortages)
Nausea and vomiting Preoperative complex carbohydrate loading
Aprepitant 1–3h prior for ≥2 risk factors
Female patients: Other non-hormonal contraception for at least
28days postoperatively
Scopolamine patch (skin behind ear for 72h); reduce patch for
children and elderly;
Intraoperative dexamethasone 8–10mg IV (half-life 36–54h); half
dose in diabetes;
Postoperative (48h): 5HT
polonosetron); dopamine (D
I (ondansetron, granisetron,
3
) antagonists (metoclopramide,
2
droperidol, prochlorperazine); Histamine-1 antagonists
(diphenhydramine, dimenhydrinate, trimethobenzamide);
Ileus Alvimopan 12mg oral if taking opioids; <15 doses due to increased
risk of MI; stop upon passing atus
Naloxegol 12.5–25mg oral
Naldemedine 0.2mg oral
Glycemic and electrolyte
imbalances
Previous short-acting insulin, SGLT-2 inhibitors, meglitinides, and
sulfonylureas should be held until eating well
Other oral agents/long-acting insulin continued at a lower dose
Basal bolus insulin therapy (BBIT) for hyperglycemia
Acute kidney injury/AKI GDFT: Enough uids to minimize risk of renal injury
Hold NSAIDs and other nephrotoxic agents
Initial bolus balanced crystalloids if AKI suspected
Urinary retention GDFT review (dehydration?); minimization of opioids
Catheterization if in doubt
Venous thromboembolism LMWHs or DOACs (>12h after neuraxial anesthesia)
Avoid rivaroxaban/dabigatran for elderly (bleeding risk)
Continue 28days in cancer/other high-risk cases
High blood pressure ACEI/ARBs re-initiated within 48h unless hypotensive
Hold antihypertensives: Systolic<90mmHg or 30% below
patient’s baseline
Atrial brillation Beta-blockers: Continue if on pre-operatively;
Beta-blockers/calcium channel blocker: Initiated if stable
Unstable: Consider cardioversion
Delirium Avoid benzodiazepines/gabapentinoids
Avoid uid fasting; clear liquids until 1–2h preoperatively
Pharmacotherapy elimination (non-essentials)
Multimodal opioid-sparing analgesia: Acetaminophen, COX-2
NSAIDs (celecoxib, meloxicam); review opioids (chronic pain);
Shock and hemorrhage Consider GDFT for raising mean arterial pressure (MAP)
Norepinephrine in non-cardiogenic shock if uid bolus inadequate
Add arginine vasopressin, milrinone if MAP still low
Non-CS acute myocardial
infarction
Consider LMWH for anticoagulation
Avoid renin-angiotensin-aldosterone inhibitors (ACEI, ARB,
spironolactone) and beta-blockers until shock resolves
(continued)
Соседние файлы в папке @xirurgi_2025
